Novartis

board

Company

select Filter
All
Business
Culture
Environment
Health
Politics
Research

Key facts

Latest news (see all)

Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs

Read: CNBC News

2024-04-23

Stocks making the biggest premarket moves: General Motors, GE Aerospace, Novartis, JetBlue and more

Read: CNBC News

2024-04-23

Novartis CEO: Broadly Positive About Business Momentum

Read: Bloomberg

2024-04-23

Novartis lifts guidance after first-quarter results beat expectations

Read: CNBC News

2024-04-23

Novartis Ups Guidance on Profit, Sales Growth

Read: The Wall Street Journal

2024-04-23

Novartis Ups Guidance on Profit, Sales Growth

Read: The Wall Street Journal

2024-04-23

Novartis wants to buy a German cancer drugmaker as it stops recruiting for its own trials

Read: Quartz

2024-04-11

Metrics

Business

assets 131.8B $
Debt 31.1B $
free cash flow 11,681,900,000.00
market cap 183,686,000,000.00
profits 24B $

Visualizations

Datasets

Source

Twitter, YAHOO-FIN, YFINANCE

Updated: 1 day ago

License

CC BY 4.0

Going further

dark About